Industry

A Defining Moment to Improve Breast Cancer Screening TORONTO–(BUSINESS WIRE)–Breast Cancer Canada welcomes today’s announcement made by the Honourable Mark Holland, Minister of Health, to temporarily pause the work of the Canadian Task Force on Preventive Health Care. This decision marks a critical opportunity to ensure that further recommendations, including breast cancer screening guidelines, are … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Hemodialysis & Peritoneal Dialysis Market (2025 Edition): Analysis By Product (Machines, Dialyzers, Dialysis Solutions, and Catheters & Accessories), By End-User, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)” report has been added to ResearchAndMarkets.com’s offering. The Global Hemodialysis & Peritoneal Dialysis market showcased growth at a CAGR of 6.66% during … [Read more…]

U.S. reported more than 209,000 cases of syphilis at all stages, including congenital syphilis, in 2023 – highest number since 1950 LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) is using an imposing image of a bottle of penicillin and a syringe and needle paired with the words “Syphilis is Curable” and the URL freeSTDcheck.org to draw … [Read more…]

PARIS–(BUSINESS WIRE)–MatriceLab Innove announced that the first large-scale randomized controlled trial investigating endometrial immune profiling showed that personalized treatment based on immune testing can significantly increase live birth rates from IVF. The trial showed that patients receiving personalized care based on MatriceLab’s UTIMPRO endometrial immune profiling test had a live birth rate (LBR) of 41.4%, … [Read more…]

A novel, allosteric and highly potent USP1 inhibitor, LAE120 exhibits robust tumor inhibitory activity across various xenograft models Significantly accelerated the progress of drug discovery leveraging cutting-edge AI models Another potential anti-tumor drug candidate, LAE118 (a mutant-selective PI3Kα inhibitor) also in IND-enabling studies LOS ANGELES–(BUSINESS WIRE)–#Biotech–Laekna (2105.HK) announced that the U.S. Food and Drug Administration … [Read more…]

Anaheim CA – March 4-7, 2025 CITY OF INDUSTRY, Calif.–(BUSINESS WIRE)–Ketone Labs, a leader in beta-hydroxybutyrate (BHB) innovation, has partnered with Blue Pacific Flavors, a premier expert in natural flavor solutions, to pioneer goBHB-powered functional beverages & nutritional products. These groundbreaking non-stimulant energy beverages featuring goBHB, offer clean, sustained energy without caffeine or taurine. The … [Read more…]

Talkdesk unlocks the transformative value for providers and payers by applying the next generation of automation to patient and member access, service, and support workflows PALO ALTO, Calif. & LAS VEGAS–(BUSINESS WIRE)–#AIAgents—Talkdesk®, Inc., a global provider of artificial intelligence (AI)-powered customer experience (CX) technology that serves enterprises of all sizes, is helping healthcare organizations effortlessly … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Pharma Handbook 2025” has been added to ResearchAndMarkets.com’s offering. The fully revised and expanded Global Pharma Handbook provides pharmaceutical industry decision-makers with a unique source of accurate, up-to-date information and analysis on prescription drug business and regulatory environments throughout the world. Coverage of over 70 individual countries (cumulatively representing more than 97% … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)” report has been added to ResearchAndMarkets.com’s offering. The Global Latent TB Testing market showcased growth at a CAGR of 10.47% during … [Read more…]

− Study met the primary endpoint, with a significantly higher proportion of clinical responders on rusfertide compared to placebo − All four key secondary endpoints were met, including EU primary endpoint and patient-reported outcomes − Rusfertide was generally well tolerated; no new safety findings were observed in the study NEWARK, Calif. & OSAKA, Japan & … [Read more…]